SARS-CoV-2 in the semen: Where does it come from?

Claudia Massarotti, Andrea Garolla, Elena Maccarini, Paola Scaruffi, Sara Stigliani, Paola Anserini, Carlo Foresta, Claudia Massarotti, Andrea Garolla, Elena Maccarini, Paola Scaruffi, Sara Stigliani, Paola Anserini, Carlo Foresta

Abstract

Background: The recent report of SARS-CoV-2 presence in semen samples of six patients, including two subjects who were recovering from the clinical disease, re-opened the discussion on possible male genital tract infection, virus shedding in semen, sexual transmission and safety of fertility treatments during the pandemic period.

Objectives: To explore current data and hypothesis on the possible sites of SARS-CoV-2 infection in the male reproduction system.

Materials and methods: We reviewed the current literature to describe: a) the evidences on angiotensin-converting enzyme 2 (AC2E) and transmembrane serine protease 2 (TMPRSS2) expression in the testes, accessory glands (including prostate) and the urinary tract; b) other coronaviruses' (SARS and MERS) ability to infect these sites.

Results: The co-expression of both ACE2 and TMPRSS2 genes was reported in spermatogonial stem cells, elongated spermatids, in at least a small percentage of prostate hillock cells and in renal tubular cells. Testicular damage was described in autopsies of SARS patients, without evidence of the virus in the specimens. Prostate is a known infection site for MERS-CoV. SARS-CoV-2 was detected in urines.

Discussion: There are still al lot of open questions on the effects of SARS-CoV-2 infection on the male reproductive tract. The presence of receptors is not a proof that the testis provides a site for viral infection and it is still unknown if SARS-CoV-2 is capable to pass the blood-testis barrier. The possibility of a prostate involvement has not been investigated yet: we have no data, but theoretically it cannot be excluded. Moreover, the RNA detected in semen could have been just a residual of urinary shedding.

Conclusion: Opening our prospective beyond the testis could be the key to better understand the possibility of a semen-related viral transmission as well as COVID19 short and long-term effects on male reproductive function.

Keywords: COVID-19; SARS-CoV-2; SARS-CoV-2 in the semen; prostate; testis.

© 2020 American Society of Andrology and European Academy of Andrology.

Figures

Figure 1
Figure 1
Levels of ACE2 and TMPRSS2 expression in human cells of the male urogenital system. n.d., not determined

References

    1. Li D, Jin M, Bao P, Zhao W, Zhang S. Clinical characteristics and results of semen tests among men with coronavirus disease 2019. JAMA Netw Open. 2020;3(5):e208292.
    1. Paoli D, Pallotti F, Turriziani O, et al. SARS‐CoV‐2 presence in seminal fluid: Myth or reality. Andrology. 2020. [Epub ahead of print]. 10.1111/andr.12825
    1. Douglas GC, O'Bryan MK, Hedger MP, et al. The novel angiotensin‐converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis. Endocrinology. 2004;145(10):4703‐4711.
    1. Chen Y, Guo Y, Pan Y, Zhao ZJ. Structure analysis of the receptor binding of 2019‐nCoV. Biochem Biophys Res Commun. 2020;525(1):135‐140.
    1. Proteinatlas . Accessed on May 10th, 2020.
    1. Abobaker A, Raba AA. Does COVID‐19 affect male fertility? World J Urol. 2020. [Epub ahead of print]. 10.1007/s00345-020-03208-w
    1. Shen Q, Xiao X, Aierken A, Liao M, Hua J. The ACE2 Expression in Sertoli cells and Germ cells may cause male reproductive disorder after SARS‐CoV‐2 Infection. OSF preprint. 2020;February:24. 10.31219/
    1. Stanley KE, Thomas E, Leave M, Wells D. Coronavirus disease (COVID‐19) and fertility: viral host entry protein expression in male and female reproductive tissues. Fert Ster. 2020;114(1):33‐43.
    1. Stopsack KH, Mucci LA, Antonarakis ES, Nelson PS, Kantoff PW. TMPRSS2 and COVID‐19: serendipity or opportunity for intervention? Cancer Discov. 2020;10(6):779‐782.
    1. Xu J, Qi L, Chi X, et al. Orchitis: a complication of severe acute respiratory syndrome (SARS). Biol Reprod. 2006;74(2):410‐416.
    1. Spencer JL, Lahon A, Tran LL, et al. Replication of zika virus in human prostate cells: a potential source of sexually transmitted virus. J Infect Dis. 2018;217(4):538‐547.
    1. Magrone T, Magrone M, Jirillo E. Focus on receptors for coronaviruses with special reference to angiotensin‐converting enzyme 2 as a potential drug target – a perspective. Endocr Metab Immune Disord Drug Targets. 2020;20(6):807‐811. 10.2174/1871530320666200427112902
    1. Chen Y‐W, Lee M‐S, Lucht A, et al. TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells. Am J Pathol. 2010;176(6):2986‐2996.
    1. Song H, Seddighzadeh B, Cooperberg MR, Huang FW. Expression of ACE2, the SARS‐CoV‐2 receptor, and TMPRSS2 in prostate epithelial cells. Eur Urol. 2020;78(2):296‐298. 10.1016/j.eururo.2020.04.065
    1. Alsaad KO, Hajeer AH, Al Balwi M, et al. Histopathology of Middle East respiratory syndrome coronovirus (MERS‐ CoV) infection — clinicopathological and ultrastructural study. Histopathology. 2018;72:516‐524.
    1. Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS‐CoV‐2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9(1):45.
    1. Wang W, Xu Y, Gao R, et al. Detection of SARS‐CoV‐2 in different types of clinical specimens. JAMA. 2020;323(18):1843‐1844.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera